The global artificial intelligence (AI) in biotechnology market size is calculated at USD 2,835 million in 2024 and is ...
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
What are "indirect costs" for universities? Why are some young scientists looking at opportunities abroad? And why are AI ...
A federal judge will soon decide whether to dismiss a lawsuit against UnitedHealth Group alleging that the company and its ...
Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...
News Medical on MSN2d
Insilico Medicine announces developmental candidate benchmarks and timelines for novel therapeutics discovered using generative AIInsilico Medicine pulls back the curtain on developmental timelines, highlighting a ~13 month average timeline to reach developmental candidate (DC) nomination across 22 programs. Insilico’s QPCTL ...
"The US and India are joining forces to develop AI technologies. We want to be on top of AI," said US President Donald Trump ...
We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...
By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback